nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC15A2—choroid plexus—malignant glioma	0.138	0.597	CbGeAlD
Cefepime—Status epilepticus—Temozolomide—malignant glioma	0.0567	0.0737	CcSEcCtD
Cefepime—Altered state of consciousness—Temozolomide—malignant glioma	0.0289	0.0376	CcSEcCtD
Cefepime—Nephropathy toxic—Carmustine—malignant glioma	0.0241	0.0313	CcSEcCtD
Cefepime—Oral candidiasis—Carmustine—malignant glioma	0.0218	0.0283	CcSEcCtD
Cefepime—Encephalopathy—Carmustine—malignant glioma	0.0215	0.028	CcSEcCtD
Cefepime—Oral candidiasis—Temozolomide—malignant glioma	0.021	0.0273	CcSEcCtD
Cefepime—Stupor—Carmustine—malignant glioma	0.0185	0.0241	CcSEcCtD
Cefepime—Cholestasis—Temozolomide—malignant glioma	0.0176	0.0229	CcSEcCtD
Cefepime—Extravasation—Carmustine—malignant glioma	0.0158	0.0206	CcSEcCtD
Cefepime—Vaginal inflammation—Temozolomide—malignant glioma	0.0134	0.0174	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0134	0.0174	CcSEcCtD
Cefepime—Depressed level of consciousness—Carmustine—malignant glioma	0.0133	0.0173	CcSEcCtD
Cefepime—Candida infection—Carmustine—malignant glioma	0.0132	0.0172	CcSEcCtD
Cefepime—Depressed level of consciousness—Temozolomide—malignant glioma	0.0129	0.0168	CcSEcCtD
Cefepime—Candida infection—Temozolomide—malignant glioma	0.0128	0.0166	CcSEcCtD
Cefepime—Coma—Carmustine—malignant glioma	0.0126	0.0164	CcSEcCtD
Cefepime—Vaginal infection—Temozolomide—malignant glioma	0.0126	0.0164	CcSEcCtD
Cefepime—Aplastic anaemia—Temozolomide—malignant glioma	0.0125	0.0163	CcSEcCtD
Cefepime—Sepsis—Carmustine—malignant glioma	0.012	0.0156	CcSEcCtD
Cefepime—Phlebitis—Carmustine—malignant glioma	0.0116	0.0151	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0111	0.0145	CcSEcCtD
Cefepime—Hepatic failure—Temozolomide—malignant glioma	0.0108	0.014	CcSEcCtD
Cefepime—SLC15A2—retina—malignant glioma	0.0105	0.0456	CbGeAlD
Cefepime—SLC15A2—telencephalon—malignant glioma	0.00968	0.042	CbGeAlD
Cefepime—SLC22A5—retina—malignant glioma	0.00915	0.0397	CbGeAlD
Cefepime—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00873	0.0113	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00855	0.0111	CcSEcCtD
Cefepime—Pancytopenia—Carmustine—malignant glioma	0.00824	0.0107	CcSEcCtD
Cefepime—Neutropenia—Carmustine—malignant glioma	0.00811	0.0105	CcSEcCtD
Cefepime—Bronchitis—Temozolomide—malignant glioma	0.00806	0.0105	CcSEcCtD
Cefepime—Pancytopenia—Temozolomide—malignant glioma	0.00796	0.0103	CcSEcCtD
Cefepime—Neutropenia—Temozolomide—malignant glioma	0.00784	0.0102	CcSEcCtD
Cefepime—Pneumonia—Carmustine—malignant glioma	0.00778	0.0101	CcSEcCtD
Cefepime—SLC15A2—medulla oblongata—malignant glioma	0.00761	0.033	CbGeAlD
Cefepime—Renal failure—Carmustine—malignant glioma	0.0076	0.00988	CcSEcCtD
Cefepime—Urinary tract infection—Carmustine—malignant glioma	0.00752	0.00977	CcSEcCtD
Cefepime—Pneumonia—Temozolomide—malignant glioma	0.00752	0.00977	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00741	0.00963	CcSEcCtD
Cefepime—Urinary tract infection—Temozolomide—malignant glioma	0.00726	0.00944	CcSEcCtD
Cefepime—Haemoglobin—Carmustine—malignant glioma	0.00698	0.00907	CcSEcCtD
Cefepime—SLC15A2—midbrain—malignant glioma	0.00695	0.0302	CbGeAlD
Cefepime—Haemorrhage—Carmustine—malignant glioma	0.00694	0.00902	CcSEcCtD
Cefepime—Hallucination—Carmustine—malignant glioma	0.00691	0.00898	CcSEcCtD
Cefepime—SLC15A2—spinal cord—malignant glioma	0.00678	0.0294	CbGeAlD
Cefepime—Haemoglobin—Temozolomide—malignant glioma	0.00674	0.00876	CcSEcCtD
Cefepime—Haemorrhage—Temozolomide—malignant glioma	0.00671	0.00872	CcSEcCtD
Cefepime—Hallucination—Temozolomide—malignant glioma	0.00668	0.00868	CcSEcCtD
Cefepime—SLC22A5—medulla oblongata—malignant glioma	0.00662	0.0287	CbGeAlD
Cefepime—Erythema multiforme—Temozolomide—malignant glioma	0.00634	0.00824	CcSEcCtD
Cefepime—SLC22A5—midbrain—malignant glioma	0.00605	0.0262	CbGeAlD
Cefepime—Erythema—Carmustine—malignant glioma	0.00604	0.00785	CcSEcCtD
Cefepime—Chills—Temozolomide—malignant glioma	0.00602	0.00782	CcSEcCtD
Cefepime—SLC22A5—spinal cord—malignant glioma	0.0059	0.0256	CbGeAlD
Cefepime—Erythema—Temozolomide—malignant glioma	0.00584	0.00759	CcSEcCtD
Cefepime—Dysgeusia—Temozolomide—malignant glioma	0.00572	0.00743	CcSEcCtD
Cefepime—Anaemia—Carmustine—malignant glioma	0.00559	0.00726	CcSEcCtD
Cefepime—Agitation—Carmustine—malignant glioma	0.00555	0.00722	CcSEcCtD
Cefepime—SLC15A2—central nervous system—malignant glioma	0.0055	0.0239	CbGeAlD
Cefepime—Leukopenia—Carmustine—malignant glioma	0.00541	0.00703	CcSEcCtD
Cefepime—Anaemia—Temozolomide—malignant glioma	0.0054	0.00702	CcSEcCtD
Cefepime—SLC15A2—cerebellum—malignant glioma	0.00538	0.0233	CbGeAlD
Cefepime—Agitation—Temozolomide—malignant glioma	0.00537	0.00698	CcSEcCtD
Cefepime—Convulsion—Carmustine—malignant glioma	0.00524	0.00681	CcSEcCtD
Cefepime—Leukopenia—Temozolomide—malignant glioma	0.00523	0.00679	CcSEcCtD
Cefepime—Convulsion—Temozolomide—malignant glioma	0.00506	0.00658	CcSEcCtD
Cefepime—Confusional state—Carmustine—malignant glioma	0.00497	0.00646	CcSEcCtD
Cefepime—Infection—Carmustine—malignant glioma	0.0049	0.00637	CcSEcCtD
Cefepime—Thrombocytopenia—Carmustine—malignant glioma	0.00483	0.00628	CcSEcCtD
Cefepime—Confusional state—Temozolomide—malignant glioma	0.00481	0.00625	CcSEcCtD
Cefepime—Anaphylactic shock—Temozolomide—malignant glioma	0.00477	0.00619	CcSEcCtD
Cefepime—Infection—Temozolomide—malignant glioma	0.00474	0.00615	CcSEcCtD
Cefepime—SLC22A5—cerebellum—malignant glioma	0.00468	0.0203	CbGeAlD
Cefepime—Thrombocytopenia—Temozolomide—malignant glioma	0.00467	0.00607	CcSEcCtD
Cefepime—Paraesthesia—Carmustine—malignant glioma	0.00443	0.00576	CcSEcCtD
Cefepime—Dyspnoea—Carmustine—malignant glioma	0.0044	0.00571	CcSEcCtD
Cefepime—SLC15A2—brain—malignant glioma	0.00437	0.0189	CbGeAlD
Cefepime—Paraesthesia—Temozolomide—malignant glioma	0.00428	0.00556	CcSEcCtD
Cefepime—Gastrointestinal disorder—Carmustine—malignant glioma	0.00426	0.00553	CcSEcCtD
Cefepime—Dyspnoea—Temozolomide—malignant glioma	0.00425	0.00552	CcSEcCtD
Cefepime—Pain—Carmustine—malignant glioma	0.00422	0.00548	CcSEcCtD
Cefepime—Constipation—Carmustine—malignant glioma	0.00422	0.00548	CcSEcCtD
Cefepime—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00411	0.00535	CcSEcCtD
Cefepime—Pain—Temozolomide—malignant glioma	0.00408	0.0053	CcSEcCtD
Cefepime—Constipation—Temozolomide—malignant glioma	0.00408	0.0053	CcSEcCtD
Cefepime—Feeling abnormal—Carmustine—malignant glioma	0.00406	0.00528	CcSEcCtD
Cefepime—Gastrointestinal pain—Carmustine—malignant glioma	0.00403	0.00524	CcSEcCtD
Cefepime—Feeling abnormal—Temozolomide—malignant glioma	0.00393	0.0051	CcSEcCtD
Cefepime—Abdominal pain—Carmustine—malignant glioma	0.0039	0.00507	CcSEcCtD
Cefepime—Body temperature increased—Carmustine—malignant glioma	0.0039	0.00507	CcSEcCtD
Cefepime—Gastrointestinal pain—Temozolomide—malignant glioma	0.0039	0.00507	CcSEcCtD
Cefepime—SLC22A5—brain—malignant glioma	0.0038	0.0165	CbGeAlD
Cefepime—Urticaria—Temozolomide—malignant glioma	0.00379	0.00492	CcSEcCtD
Cefepime—Abdominal pain—Temozolomide—malignant glioma	0.00377	0.0049	CcSEcCtD
Cefepime—Body temperature increased—Temozolomide—malignant glioma	0.00377	0.0049	CcSEcCtD
Cefepime—Hypersensitivity—Carmustine—malignant glioma	0.00363	0.00472	CcSEcCtD
Cefepime—Hypersensitivity—Temozolomide—malignant glioma	0.00351	0.00456	CcSEcCtD
Cefepime—Diarrhoea—Carmustine—malignant glioma	0.00337	0.00439	CcSEcCtD
Cefepime—Pruritus—Temozolomide—malignant glioma	0.00337	0.00438	CcSEcCtD
Cefepime—Dizziness—Carmustine—malignant glioma	0.00326	0.00424	CcSEcCtD
Cefepime—Diarrhoea—Temozolomide—malignant glioma	0.00326	0.00424	CcSEcCtD
Cefepime—Dizziness—Temozolomide—malignant glioma	0.00315	0.0041	CcSEcCtD
Cefepime—Vomiting—Carmustine—malignant glioma	0.00314	0.00408	CcSEcCtD
Cefepime—Rash—Carmustine—malignant glioma	0.00311	0.00404	CcSEcCtD
Cefepime—Dermatitis—Carmustine—malignant glioma	0.00311	0.00404	CcSEcCtD
Cefepime—Headache—Carmustine—malignant glioma	0.00309	0.00402	CcSEcCtD
Cefepime—Vomiting—Temozolomide—malignant glioma	0.00303	0.00394	CcSEcCtD
Cefepime—Rash—Temozolomide—malignant glioma	0.00301	0.00391	CcSEcCtD
Cefepime—Dermatitis—Temozolomide—malignant glioma	0.003	0.0039	CcSEcCtD
Cefepime—Headache—Temozolomide—malignant glioma	0.00299	0.00388	CcSEcCtD
Cefepime—Nausea—Carmustine—malignant glioma	0.00293	0.00381	CcSEcCtD
Cefepime—Nausea—Temozolomide—malignant glioma	0.00283	0.00368	CcSEcCtD
